Clinical trial
The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer
NCT00188604 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188604 |
|---|---|
| Title | The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer |
| Official title | A Randomized Phase II Placebo-controlled Double Blind Study of Using Selenium in the Treatment of Secondary Lymphedema in Breast Cancer Patients |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms, Lymphedema |
| Intervention type | Drug |
| Interventions | sodium selenite |
| Enrollment | 34 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 13, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: